Schwartz GK - Search Results

1

Loss of heterozygosity and homozygous deletion of the tpr locus in human gastric cancer.

Cunningham JD, Schwartz GK, Karpeh M, Blundell M, Kelson DP, Jhanwar SC, Albino AP. Cunningham JD, et al. Among authors: schwartz gk. Am J Surg. 1997 Jun;173(6):521-2. doi: 10.1016/s0002-9610(97)00011-1. Am J Surg. 1997. PMID: 9207167

2

Potentiation of apoptosis by treatment with the protein kinase C-specific inhibitor safingol in mitomycin C-treated gastric cancer cells.

Schwartz GK, Haimovitz-Friedman A, Dhupar SK, Ehleiter D, Maslak P, Lai L, Loganzo F Jr, Kelsen DP, Fuks Z, Albino AP. Schwartz GK, et al. J Natl Cancer Inst. 1995 Sep 20;87(18):1394-9. doi: 10.1093/jnci/87.18.1394. J Natl Cancer Inst. 1995. PMID: 7658500

3

The mutational status of p53 protein in gastric and esophageal adenocarcinoma cell lines predicts sensitivity to chemotherapeutic agents.

Nabeya Y, Loganzo F Jr, Maslak P, Lai L, de Oliveira AR, Schwartz GK, Blundell ML, Altorki NK, Kelsen DP, Albino AP. Nabeya Y, et al. Among authors: schwartz gk. Int J Cancer. 1995 Feb 20;64(1):37-46. doi: 10.1002/ijc.2910640109. Int J Cancer. 1995. PMID: 7665247

4

Defining the invasive phenotype of proximal gastric cancer cells.

Schwartz GK, Wang H, Lampen N, Altorki N, Kelsen D, Albino AP. Schwartz GK, et al. Cancer. 1994 Jan 1;73(1):22-7. doi: 10.1002/1097-0142(19940101)73:1<22::aid-cncr2820730106>3.0.co;2-o. Cancer. 1994. PMID: 8275429

5

Characterization of cell lines established from human gastric-esophageal adenocarcinomas. Biologic phenotype and invasion potential.

Altorki N, Schwartz GK, Blundell M, Davis BM, Kelsen DP, Albino AP. Altorki N, et al. Among authors: schwartz gk. Cancer. 1993 Aug 1;72(3):649-57. doi: 10.1002/1097-0142(19930801)72:3<649::aid-cncr2820720305>3.0.co;2-l. Cancer. 1993. PMID: 8334620

6

Protein kinase C: a novel target for inhibiting gastric cancer cell invasion.

Schwartz GK, Jiang J, Kelsen D, Albino AP. Schwartz GK, et al. J Natl Cancer Inst. 1993 Mar 3;85(5):402-7. doi: 10.1093/jnci/85.5.402. J Natl Cancer Inst. 1993. PMID: 8433394

7

Alteration in cholesteatoma fibroblasts: induction of neoplastic-like phenotype.

Parisier SC, Agresti CJ, Schwartz GK, Han JC, Albino AP. Parisier SC, et al. Among authors: schwartz gk. Am J Otol. 1993 Mar;14(2):126-30. Am J Otol. 1993. PMID: 8503484

8

Neoadjuvant therapy of high-risk gastric cancer: a phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil.

Kelsen D, Karpeh M, Schwartz G, Gerdes H, Lightdale C, Botet J, Lauers G, Klimstra D, Huang Y, Saltz L, Quan V, Brennan M. Kelsen D, et al. J Clin Oncol. 1996 Jun;14(6):1818-28. doi: 10.1200/JCO.1996.14.6.1818. J Clin Oncol. 1996. PMID: 8656250 Clinical Trial.

9

Chemotherapy and P-glycoprotein expression in chondrosarcoma.

Terek RM, Schwartz GK, Devaney K, Glantz L, Mak S, Healey JH, Albino AP. Terek RM, et al. Among authors: schwartz gk. J Orthop Res. 1998 Sep;16(5):585-90. doi: 10.1002/jor.1100160510. J Orthop Res. 1998. PMID: 9820282

10

The checkpoint kinase inhibitor AZD7762 potentiates chemotherapy-induced apoptosis of p53-mutated multiple myeloma cells.

Landau HJ, McNeely SC, Nair JS, Comenzo RL, Asai T, Friedman H, Jhanwar SC, Nimer SD, Schwartz GK. Landau HJ, et al. Among authors: schwartz gk. Mol Cancer Ther. 2012 Aug;11(8):1781-8. doi: 10.1158/1535-7163.MCT-11-0949. Epub 2012 May 31. Mol Cancer Ther. 2012. PMID: 22653969

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

302 results

Search Page

Filters